Total pathway to method validation

Clin Chem Lab Med. 2020 Oct 25;58(11):e257-e261. doi: 10.1515/cclm-2020-0525.

Gerald Woollard^{1

2}, Brett McWhinney^{1

3}, Ronda F Greaves^{1

4

5

6

7}, Wilson Punyalack^{1

8}

¹ Member RCPAQAP-AACB Advisory Committees, St Leonards, NSW, Australia.
² Department of Pathology and Laboratory Medicine, Auckland City Hospital, Auckland, New Zealand.
³ Analytical Chemistry Unit, Department of Chemical Pathology, RBWH, Herston, QLD, Australia.
⁴ Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, VIC, Australia.
⁵ Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
⁶ School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
⁷ Executive, Emerging Technologies Division, International Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy.
⁸ The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), St Leonards, NSW, Australia.

No abstract available

Keywords: development; method validation; post-development; pre-developmental.

Publication types